Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$246,487 | -$2,146,318 | $47,312 | -$12,206 |
| Dep. & Amort. | $96,445 | $226,093 | $33,362 | $9,403 |
| Deferred Tax | $0 | -$18,521 | $9,528 | $1,951 |
| Stock-Based Comp. | $58,892 | $182,894 | $38,937 | $3,037 |
| Change in WC | $551,033 | $478,660 | -$49,516 | -$21,123 |
| Other Non-Cash | -$381,066 | $1,482,379 | -$136,358 | -$4,827 |
| Operating Cash Flow | $65,114 | $205,187 | -$56,735 | -$23,765 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$16,161 | -$601,657 | -$424,544 | -$15,236 |
| Net Acquisitions | $0 | $0 | -$365,210 | -$13,668 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $10,850 | $0 | $0 |
| Other Inv. Act. | $13,165 | $10,879 | $365,914 | $13,760 |
| Investing Cash Flow | -$2,996 | -$590,778 | -$423,840 | -$15,144 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $354,400 | $2,642 |
| Stock Repurch. | $0 | -$31,646 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,658 | $306,153 | $603,532 | $40,723 |
| Financing Cash Flow | -$44,649 | $306,153 | $603,532 | $40,723 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | -$79,438 | $122,957 | $1,814 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52,240 | $131,678 | $8,721 | $6,907 |
| End Cash | $69,709 | $52,240 | $131,678 | $8,721 |
| Free Cash Flow | $48,120 | -$396,470 | -$481,279 | -$39,001 |